Gagandeep Brar, MD

BCLC B intermediate stage hepatocellular carcinoma, defined as patients with unresectable, liver-limited disease and preserved liver function, encompasses a broad range of patients with variable tumor size, number, and location.

Gagandeep Brar, MD, discusses the rise of new treatment approaches in hepatocellular carcinoma.

Gagandeep Brar, MD, discusses the need to identify biomarkers in hepatocellular carcinoma.

Gagandeep Brar, MD, reflects on patient interactions that she has encountered throughout her fellowship.